Bio-Rad Laboratories and Caliper Life Sciences have announced a new collaboration, under which the companies will study the feasibility of developing a new microfluidics system platform
The two companies' previous collaboration, initiated in mid-2003, resulted in the successful launch of a new microfluidics-based electrophoresis product, Experion, in the autumn of 2004.
"The success we've enjoyed with the Experion automated electrophoresis system has confirmed our belief that microfluidics is a key strategic technology," commented Norman Schwartz, president and CEO at Bio-Rad.
"After our first positive experience collaborating with Caliper, we are looking forward to this next collaboration where we will pursue new ideas regarding LabChip microfluidics as the foundation for innovative, new products".
Kevin Hrusovsky, Caliper's president and CEO, also commented, "Bio-Rad is a model partner for our 'Caliper Driven' programme, under which we enable life science companies like Bio-Rad to tap into our innovative technologies, expertise and patent portfolio".
"Their strong reputation in life sciences and diagnostics, and their well-established global distribution very effectively leverage our technology into key markets".Bio-Rad Laboratories is a multinational manufacturer and distributor of life science research products and clinical diagnostics.
It is based in Hercules, California, and serves more than 70,000 research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices.
Caliper Life Sciences uses its advanced liquid handling and LabChip technologies to create leading edge tools that accelerate drug discovery, enable diagnosis of disease and facilitate scientific research.
Caliper headquarters are located in Hopkinton, Massachusetts, with R+D, operations and manufacturing facilities for LabChip devices in Mountain View, California, and direct sales, service and applications support throughout the world.
Caliper customers and partners include many of the largest pharmaceutical, biotechnology, and life sciences companies.
